Meda.Ns
MEDA.NS operates in the healthcare services and equipment sector, providing managed healthcare solutions and generating revenue primarily through service delivery and equipment sales.
Business. MEDA.NS operates in the healthcare services and equipment sector, providing managed healthcare solutions and generating revenue primarily through service delivery and equipment sales.
Analyst recommendations
3 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
MEDA.NS operates in the healthcare services and equipment sector, providing managed healthcare solutions and generating revenue primarily through service delivery and equipment sales.
MEDA.NS maintains a relatively strong liquidity position, with a current ratio of 1.49, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's net cash position is negative after subtracting total debt, which suggests potential liquidity constraints. The company's cash and equivalents amount to INR 548.8 million, while its long-term debt stands at INR 2.04 billion, resulting in a debt-to-equity ratio of 0.38.
In terms of profitability, MEDA.NS demonstrates a return on equity (ROE) of 16.78% and a return on assets (ROA) of 7.85%, both of which are strong indicators of efficient capital utilization and profitability. These figures suggest the company is generating solid returns relative to its equity and asset base. The operating income of INR 1.00 billion and net income of INR 908.79 million further support the company's profitability.
The company's revenue is concentrated in the healthcare services and equipment segment, with no disclosed geographic diversification. This concentration may expose the company to specific market risks, particularly in the healthcare sector, where demand can be sensitive to regulatory and economic changes.
Looking at the growth trajectory, MEDA.NS has reported a revenue of INR 7.23 billion, with a gross profit of INR 7.19 billion. While the company has shown consistent profitability, the outlook for future revenue growth is not explicitly detailed in the available data. The company's capital expenditure of INR 457.93 million indicates ongoing investment in infrastructure and operations.
The risk assessment for MEDA.NS highlights a medium liquidity risk and a low dilution risk. The company's net cash position being negative after subtracting total debt is a key flag, suggesting potential challenges in maintaining liquidity. However, the low dilution risk indicates that the company is not expected to issue additional shares in the near term, which is a positive sign for existing shareholders.
Recent events and filings do not provide specific details on new developments or strategic initiatives for MEDA.NS. The company's financial performance and risk profile remain stable, with no significant changes reported in the latest available data.
- MEDA.NS has a strong return on equity (16.78%) and return on assets (7.85%), indicating efficient capital utilization and profitability.
- The company's liquidity position is moderate, with a current ratio of 1.49, but its net cash position is negative after subtracting total debt.
- The debt-to-equity ratio of 0.38 suggests a balanced capital structure with manageable leverage.
- The company's revenue is concentrated in the healthcare services and equipment segment, with no disclosed geographic diversification.
- The risk assessment indicates a medium liquidity risk and a low dilution risk, suggesting potential challenges in maintaining liquidity but minimal threat to existing shareholders.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 7,45 |
| Revenue | —no estimate | —no estimate | 9,1B INR |
| Operating income | —no estimate | —no estimate | 912,5M INR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- MEDA.NS Market data — financials · 2026-05-28
- Medi Assist Healthcare Services Ltd Market data — analyst estimates · 2026-05-28
Ownership & reference
Leadership
- Vikram Jit Singh ChhatwalExecutive Chairman of the Board